1l8g

From Proteopedia

---

Revision as of 15:51, 12 November 2007

proteopedia linkproteopedia link

spinqualitylabelsall models 1l8g, resolution 2.5Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Crystal structure of PTP1B complexed with 7-(1,1-Dioxo-1H-benzo[d]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid

Contents 1 Overview 2 Disease 3 About this Structure 4 Reference

Overview

Utilizing structure-based design, we have previously demonstrated that it, is possible to obtain selective inhibitors of protein-tyrosine phosphatase, 1B (PTP1B). A basic nitrogen was introduced into a general PTP inhibitor, to form a salt bridge to Asp48 in PTP1B and simultaneously cause repulsion, in PTPs containing an asparagine in the equivalent position [Iversen, L., F., et al. (2000) J. Biol. Chem. 275, 10300-10307]. Further, we have, recently demonstrated that Gly259 in PTP1B forms the bottom of a gateway, that allows easy access to the active site for a broad range of, substrates, while bulky residues in the same position in other PTPs cause, steric hindrance and reduced substrate recognition capacity [Peters, G., H., et al. (2000) J. Biol. Chem. 275, 18201-18209]. The current study was, undertaken to investigate the feasibility of structure-based design, utilizing these differences in accessibility to the active site among, various PTPs. We show that a general, low-molecular weight PTP inhibitor, can be developed into a highly selective inhibitor for PTP1B and TC-PTP by, introducing a substituent, which is designed to address the region around, residues 258 and 259. Detailed enzyme kinetic analysis with a set of, wild-type and mutant PTPs, X-ray protein crystallography, and molecular, modeling studies confirmed that selectivity for PTP1B and TC-PTP was, achieved due to steric hindrance imposed by bulky position 259 residues in, other PTPs.

Disease

Known diseases associated with this structure: Abdominal body fat distribution, modifier of OMIM:[176885], Insulin resistance, susceptibility to OMIM:[176885]

About this Structure

1L8G is a Single protein structure of sequence from Homo sapiens with DBD as ligand. Active as Protein-tyrosine-phosphatase, with EC number 3.1.3.48 Full crystallographic information is available from OCA.

Reference

Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases., Iversen LF, Andersen HS, Moller KB, Olsen OH, Peters GH, Branner S, Mortensen SB, Hansen TK, Lau J, Ge Y, Holsworth DD, Newman MJ, Hundahl Moller NP, Biochemistry. 2001 Dec 11;40(49):14812-20. PMID:11732900

Page seeded by OCA on Mon Nov 12 17:57:38 2007